Literature DB >> 7963141

Antigen-reduced infant formulas versus human milk: growth and metabolic parameters in the first 6 months of life.

M Giovannini1, C Agostoni, A Fiocchi, R Bellú, S Trojan, E Riva.   

Abstract

OBJECTIVE: To compare growth and metabolic parameters of infants fed special formulas for atopy prevention to breast-fed infants.
METHODS: Eighty-two infants with family history of IgE-mediated diseases completed a 6-month nutritional follow-up within a clinical trial to assess the effectiveness of the dietary intervention in preventing atopy. Infants were subdivided according to the type of milk feeding from the end of the first month of life up to sixth month: human milk (HM) group (29 infants); soy formula (SF) group (15 infants); whey-based low-degree hydrolysate (WHy) group (15 infants); casein-based high-degree hydrolysate (CHy) group (13 infants); soy plus collagen-based high-degree hydrolysate group (10 infants). Anthropometric indices were determined at 0, 3 and 6 months of life and a fasting blood sample for hematochemical parameters was obtained at 5 months of life before beginning the introduction of solid foods.
RESULTS: Lower values of body mass index and higher blood urea nitrogen were displayed by the CHy group at 3 months. Plasma aminoacidograms showed higher essential amino acids (AA)/total AA in SF, WHy and CHy groups but lower branched chain AA/essential AA in all formula-fed infants in comparison with the HM group.
CONCLUSIONS: Special formulas (in particular high-degree protein hydrolysates) should be carefully evaluated when used for prolonged periods of time in healthy infants at familial risk of atopy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963141     DOI: 10.1080/07315724.1994.10718422

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  13 in total

Review 1.  Diet, sensitive periods in flavour learning, and growth.

Authors:  Jillian C Trabulsi; Julie A Mennella
Journal:  Int Rev Psychiatry       Date:  2012-06

2.  Differential growth patterns among healthy infants fed protein hydrolysate or cow-milk formulas.

Authors:  Julie A Mennella; Alison K Ventura; Gary K Beauchamp
Journal:  Pediatrics       Date:  2010-12-27       Impact factor: 7.124

Review 3.  Efficacy of screening immune system function in at-risk newborns.

Authors:  Christopher J Pavlovski
Journal:  Australas Med J       Date:  2014-07-31

Review 4.  Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.

Authors:  David A Osborn; John Kh Sinn; Lisa J Jones
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

5.  World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines.

Authors:  Alessandro Fiocchi; Jan Brozek; Holger Schünemann; Sami L Bahna; Andrea von Berg; Kirsten Beyer; Martin Bozzola; Julia Bradsher; Enrico Compalati; Motohiro Ebisawa; Maria Antonieta Guzman; Haiqi Li; Ralf G Heine; Paul Keith; Gideon Lack; Massimo Landi; Alberto Martelli; Fabienne Rancé; Hugh Sampson; Airton Stein; Luigi Terracciano; Stefan Vieths
Journal:  World Allergy Organ J       Date:  2010-04-23       Impact factor: 4.084

Review 6.  Soy formula for prevention of allergy and food intolerance in infants.

Authors:  D A Osborn; J Sinn
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

7.  Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons.

Authors:  Cara J Westmark
Journal:  Front Nutr       Date:  2017-01-18

8.  Levels of inflammatory cytokines from peripheral blood mononuclear cells of children with cow's milk protein allergy.

Authors:  Maria D'Apolito; Angelo Campanozzi; Ida Giardino; Massimo Pettoello-Mantovani
Journal:  Turk Pediatri Ars       Date:  2017-12-01

9.  Infant formulas containing hydrolysed protein for prevention of allergic disease.

Authors:  David A Osborn; John Kh Sinn; Lisa J Jones
Journal:  Cochrane Database Syst Rev       Date:  2018-10-19

10.  Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates.

Authors:  Shoichiro Amari; Sadequa Shahrook; Fumihiko Namba; Erika Ota; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2020-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.